Literature DB >> 24043501

Treatment of Tourette syndrome.

Roger M Kurlan1.   

Abstract

Tourette's syndrome (TS) consists of chronic motor and phonic tics and characteristically begins in childhood. The tics can be disabling and commonly associated behavioral comorbities such as attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD), can also cause problems in daily functioning. The underlying etiology and neurobiology of TS remain unknown although genetic factors appear to be important, cortical control of basal ganglia motor function appears to be disturbed and neurochemical abnormalities, particularly involving dopamine neurotransmission, are likely present. The treatment of TS involves appropriate education and support. Tics can be treated with habit reversal cognitive behavioral therapy, medications (most commonly alpha agonists and antipsychotics), local intramuscular injections of botulinum toxin and some severe, refractory cases have responded to deep brain stimulation surgery (DBS). It is important to appropriately diagnose and treat comorbid behavioral disorders that are disrupting function. OCD can be treated with cognitive behavioral therapy, selective serotonin reuptake inhibitors, and atypical antipsychotics. DBS has become a treatment option for patients with disabling OCD despite other therapies. ADHD is treated with appropriate classroom accommodations, behavioral therapy, alpha agonists, atomoxetine or methylphenidate-containing stimulant drugs.

Entities:  

Mesh:

Year:  2014        PMID: 24043501      PMCID: PMC3899474          DOI: 10.1007/s13311-013-0215-4

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  28 in total

1.  Short-term versus longer term pimozide therapy in Tourette's syndrome: a preliminary study.

Authors: 
Journal:  Neurology       Date:  1999-03-10       Impact factor: 9.910

2.  A placebo-controlled trial of risperidone in Tourette syndrome.

Authors:  L Scahill; J F Leckman; R T Schultz; L Katsovich; B S Peterson
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

3.  Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome.

Authors:  Paul S A Kalanithi; Wei Zheng; Yuko Kataoka; Marian DiFiglia; Heidi Grantz; Clifford B Saper; Michael L Schwartz; James F Leckman; Flora M Vaccarino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-30       Impact factor: 11.205

4.  Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial.

Authors:  Yves Dion; Lawrence Annable; Paul Sandor; Guy Chouinard
Journal:  J Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.153

5.  Clonidine treatment of Gilles de la Tourette's syndrome.

Authors:  J F Leckman; M T Hardin; M A Riddle; J Stevenson; S I Ort; D J Cohen
Journal:  Arch Gen Psychiatry       Date:  1991-04

6.  Botulinum toxin in the treatment of tics.

Authors:  C H Kwak; P A Hanna; J Jankovic
Journal:  Arch Neurol       Date:  2000-08

7.  Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.

Authors:  A J Allen; R M Kurlan; D L Gilbert; B J Coffey; S L Linder; D W Lewis; P K Winner; D W Dunn; L S Dure; F R Sallee; D R Milton; M I Mintz; R K Ricardi; G Erenberg; L L Layton; P D Feldman; D K Kelsey; T J Spencer
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

Review 8.  Contemporary assessment and pharmacotherapy of Tourette syndrome.

Authors:  Lawrence Scahill; Gerald Erenberg; Cheston M Berlin; Cathy Budman; Barbara J Coffey; Joseph Jankovic; Louise Kiessling; Robert A King; Roger Kurlan; Anthony Lang; Jonathan Mink; Tanya Murphy; Samual Zinner; John Walkup
Journal:  NeuroRx       Date:  2006-04

9.  Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder.

Authors:  Kenneth D Gadow; Jeffrey Sverd; Edith E Nolan; Joyce Sprafkin; Jayne Schneider
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-07       Impact factor: 8.829

10.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

View more
  12 in total

1.  Editorial: Neurotherapeutics of movement disorders.

Authors:  Stewart A Factor; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 2.  Tourette Syndrome: Update.

Authors:  Mark Hallett
Journal:  Brain Dev       Date:  2015-01-17       Impact factor: 1.961

Review 3.  Botulinum toxin for motor and phonic tics in Tourette's syndrome.

Authors:  Sanjay Pandey; Prachaya Srivanitchapoom; Richard Kirubakaran; Brian D Berman
Journal:  Cochrane Database Syst Rev       Date:  2018-01-05

Review 4.  Modeling tics in rodents: Conceptual challenges and paths forward.

Authors:  Marco Bortolato; Christopher Pittenger
Journal:  J Neurosci Methods       Date:  2017-02-22       Impact factor: 2.390

5.  Association between DRD2/ANKK1 TaqIA Polymorphism and Susceptibility with Tourette Syndrome: A Meta-Analysis.

Authors:  Aihua Yuan; Liang Su; Shunying Yu; Chunbo Li; Tao Yu; Jinhua Sun
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

6.  Dysfunctions of the basal ganglia-cerebellar-thalamo-cortical system produce motor tics in Tourette syndrome.

Authors:  Daniele Caligiore; Francesco Mannella; Michael A Arbib; Gianluca Baldassarre
Journal:  PLoS Comput Biol       Date:  2017-03-30       Impact factor: 4.475

7.  The Efficacy and Tolerability of the Clonidine Transdermal Patch in the Treatment for Children with Tic Disorders: A Prospective, Open, Single-Group, Self-Controlled Study.

Authors:  Pan-Pan Song; Li Jiang; Xiu-Juan Li; Si-Qi Hong; Shuang-Zi Li; Yue Hu
Journal:  Front Neurol       Date:  2017-02-23       Impact factor: 4.003

8.  Effects of single-session cathodal transcranial direct current stimulation on tic symptoms in Tourette's syndrome.

Authors:  Katherine Dyke; Georgina M Jackson; Elena Nixon; Stephen R Jackson
Journal:  Exp Brain Res       Date:  2019-08-28       Impact factor: 1.972

9.  Deep Brain Stimulation of the Globus Pallidus Internus in Patients with Intractable Tourette Syndrome: A 1-year Follow-up Study.

Authors:  Xiao-Hua Zhang; Jian-Yu Li; Yu-Qing Zhang; Yong-Jie Li
Journal:  Chin Med J (Engl)       Date:  2016-05-05       Impact factor: 2.628

Review 10.  The Relationship between Neurocircuitry Dysfunctions and Attention Deficit Hyperactivity Disorder: A Review.

Authors:  Yuncheng Zhu; Daoliang Yang; Weidong Ji; Tianming Huang; Lianxue Xue; Xixi Jiang; Liangliang Chen; Fang Wang
Journal:  Biomed Res Int       Date:  2016-09-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.